维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Wishahi M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Clinical and biochemical studies of bone destruction in cholesteatoma显示文摘	AMAR M S WISHAHI H F ZAKHARY M M	1996	J Laryngol Otol1996，110，：	1
	2	Anatomy of the spermatic venous plexus (pampiniform plexus)in men with and without varicocele :intraoperative venographic study显示文摘	MOHAMED M WISHAHI	1992	J Urol1992，147，5：	1
	3	What happens if nothing happens?-History of an untreated urothelial carcinoma of the bladder显示文摘	Gerullis H Ecke TH Wishahi M	2010	J Egypt Soc Parasitol2010，40，3：	1
	4	TGF-Bl pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal显示文摘	Shaker O Hammam O Wishahi M	2013	Urol Oncol2013，31，3：	1
	5	Superiority of fluores- cent in situ hybridization over immunohistochemistry in detection of HER2 gene in carcinoma of the urinary bladder associated with and without schistosomiasis 显示文摘	Hammam O Wishahi M Hindawi A	2014	J Egypt Soc Parasitol2014，44，3：	1
	6	Multidisciplinary basic and clinical research of acute kidney injury with COVID-19:Pathophysiology,mechanisms,incidence,management and kidney transplantation显示文摘Acute kidney injury(AKI)linked to coronavirus disease 2019(COVID-19)has been identified in the course of the disease.AKI can be mild or severe and that is dependent on the presence of comorbidities and the severity of COVID-19.Among patients who had been hospitalized with COVID-19,some were admitted to intensive care unit.The etiology of AKI associated with COVID-19 is multifactorial.Prevention of severe AKI is the prime task in patients with COVID-19 that necessitates a battery of measurements and precautions in management.Patients with AKI who have needed dialysis are in an increased risk to develop chronic kidney disease(CKD)or a progression of their existing CKD.Kidney transplantation patients with COVID-19 are in need of special management to adjust the doses of immunosuppression drugs and corticosteroids to guard against graft rejection but not to suppress the immune system to place the patient at risk of developing a COVID-19 infection.Immunosuppression drugs and corticosteroids for patients who have had a kidney transplant has to be adjusted based on laboratory results and is individualized aiming at the protection of the transplanted from rejection.	Mohamed Wishahi Nabawya M Kamal	2022	World Journal of Nephrology2022，11，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费